Approvals/CIMA-AEMPS/OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA AUROVITAS 40 MG/5 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA AUROVITAS 40 MG/5 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Aurovitas Spain, S.A.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: e581d7e32fd63ab0
Drug Cima Aemps Name: OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA AUROVITAS 40 MG/5 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 86250
Holder Company Name: Aurovitas Spain, S.A.U.
Marketing Company Name: Aurovitas Spain, S.A.U.
Authorization Date: 2021-11-02
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 40 mg/ 5 mg/ 25 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Aurovitas Spain, S.A.U.

OLMESARTAN MEDOXOMILO

40 mg

AMLODIPINO BESILATO

6,93 mg

HIDROCLOROTIAZIDA

25 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 2, 2021

Approval ID

e581d7e32fd63ab0

Type

Standard